curculigoside has been researched along with Disease Models, Animal in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Ding, X; Huang, H; Ji, L; Jiang, J; Li, F; Lu, D; Zhao, P | 1 |
Bai, R; Cui, R; Jiang, S; Lai, A; Li, S; Liang, W; Liu, S; Tan, S; Wang, W; Xu, J; Zhang, G; Zheng, M | 1 |
Song, ZJ; Wang, XC; Wu, SB; Yang, SJ; Zhang, ZR; Zhu, GQ | 1 |
3 other study(ies) available for curculigoside and Disease Models, Animal
Article | Year |
---|---|
Curculigoside mitigates dextran sulfate sodium‑induced colitis by activation of KEAP1‑NRF2 interaction to inhibit oxidative damage and autophagy of intestinal epithelium barrier.
Topics: Animals; Autophagy; Caco-2 Cells; Colitis; Colitis, Ulcerative; Dextran Sulfate; Disease Models, Animal; Humans; Hydrogen Peroxide; Intestinal Mucosa; Kelch-Like ECH-Associated Protein 1; Mice; NF-E2-Related Factor 2; Oxidative Stress; Tumor Necrosis Factor-alpha | 2023 |
Curculigoside exerts significant anti‑arthritic effects in vivo and in vitro via regulation of the JAK/STAT/NF‑κB signaling pathway.
Topics: Animals; Arthritis, Rheumatoid; Benzoates; Cell Proliferation; Collagen Type II; Disease Models, Animal; Gene Expression; Glucosides; Humans; I-kappa B Proteins; Interleukins; Janus Kinase 1; Janus Kinase 3; Rats; Signal Transduction; STAT3 Transcription Factor; Synoviocytes; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2019 |
Curculigoside facilitates fear extinction and prevents depression-like behaviors in a mouse learned helplessness model through increasing hippocampal BDNF.
Topics: Animals; Behavior, Animal; Benzoates; Brain-Derived Neurotrophic Factor; Depression; Disease Models, Animal; Glucosides; Helplessness, Learned; Hippocampus; Male; Medicine, Chinese Traditional; Mice; Mice, Inbred C57BL | 2019 |